Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10822312 Substituted quinazoline compounds and methods of use

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 3, 2020

Patent Application Number

16089000

Date Filed

March 29, 2017

Patent Citations

US Patent 10023588 Compositions and methods for treating cancer

US Patent 10011600 Methods and compositions for inhibition of Ras

Patent Citations Received

US Patent 11377441 Covalent inhibitors of KRAS

US Patent 11358959 Benzothiophene and benzothiazole compounds and methods of use thereof

US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

0

US Patent 11912723 KRAS modulators and uses thereof

0

US Patent 11639346 Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS

0

US Patent 11274093 Fused bicyclic benzoheteroaromatic compounds and methods of use thereof

US Patent 11279689 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer

Patent Primary Examiner

Emily A Bernhardt

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10822312 Substituted quinazoline compounds and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool